EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

The use of a saliva substitute as treatment for xerostomia in Sjögren's syndrome--a case report


Oral Surgery, Oral Medicine, and Oral Pathology 52(4): 384-386
The use of a saliva substitute as treatment for xerostomia in Sjögren's syndrome--a case report

(PDF same-day service: $19.90)

Accession: 044774906

PMID: 6946360

DOI: 10.1016/0030-4220(81)90335-2



Related references

Treatment of xerostomia with polymer-based saliva substitutes in patients with Sjogren's syndrome. Arthritis and Rheumatism 39(1): 57-63, 1996

Xerostomia (Sjögren's syndrome) associated with unusual dental caries. Report of a case. Oral Surgery, Oral Medicine, and Oral Pathology 21(1): 34-38, 1966

Treatment of xerostomia through use of dentures containing reservoirs of saliva substitute. Proceedings of the Finnish Dental Society. Suomen Hammaslaakariseuran Toimituksia 85(1): 47-50, 1989

Taste function in xerostomia before and after treatment with a saliva substitute containing carboxymethylcellulose. Journal of Otolaryngology 34(2): 116-120, 2005

Evaluation of a saliva substitute developed for postirradiation xerostomia treatment 2 Five-year experience. Acta Stomatologica Croatica 29(1): 33-40, 1995

Evaluation of a saliva substitute developed for postirradiation xerostomia treatment 1. a pilot study. Chirurgia Maxillofacialis and Plastica 16(3): 123-129, 1986

Comparison between saliva stimulants and a saliva substitute in patients with xerostomia and hyposalivation. Special Care in Dentistry 18(4): 142-148, 1999

Cytokine concentrations in stimulated whole saliva among patients with primary Sjögren's syndrome, secondary Sjögren's syndrome, and patients with primary Sjögren's syndrome receiving varying doses of interferon for symptomatic treatment of the condition: a preliminary study. Clinical Oral Investigations 5(2): 133-135, 2001

Saliva substitute in xerostomic patients with primary Sjögren's syndrome: a single-blind trial. Quintessence International 35(5): 392-396, 2004

Chemokine saliva levels in patients with primary Sjögren's syndrome, associated Sjögren's syndrome, pre-clinical Sjögren's syndrome and systemic autoimmune diseases. Rheumatology 50(7): 1288-1292, 2012